恐怖症治療の世界市場

恐怖症治療の世界市場は2030年までに24億米ドルに達する見込み

2024年に19億米ドルと推定される恐怖症治療の世界市場は、2024年から2030年にかけてCAGR 4.0％で成長し、2030年には24億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである動物恐怖症は、CAGR 5.2％を記録し、分析期間終了時には7億7,150万米ドルに達すると予測されます。先端恐怖症分野の成長率は、分析期間中CAGR 2.8％と推定されます。

米国市場は5億2,700万米ドルと推定、中国はCAGR 7.5％で成長予測

米国の恐怖症治療市場は、2024年に5億2,700万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを7.5%として、2030年までに5億240万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.5%と3.1%と予測されています。欧州では、ドイツがCAGR 2.3%で成長すると予測されています。

世界の恐怖症治療市場- 主要動向と促進要因のまとめ

恐怖症治療の需要が人口動態や地域を問わず高まっているのはなぜか？

恐怖症は、特定の対象、状況、活動に対する強烈で不合理な恐怖として分類され、専門家の介入を必要とする深刻な精神衛生状態として認識されるようになってきています。先進国でも発展途上国でも、メンタルヘルスに対する意識が高まるにつれ、社交恐怖症、広場恐怖症、高所恐怖症、クモ恐怖症、飛行恐怖症、閉鎖空間恐怖症など、さまざまな種類の恐怖症の治療を求める人が増えています。かつては心理的な状態につきまとっていたスティグマ（烙印）は徐々に減少し、より多くの人々が診断や治療を受けるようになっています。これと並行して、ヘルスケアシステムや政府は、メンタルヘルスサービスをプライマリーケアに統合し、恐怖症治療をより利用しやすくしています。さらに、COVID-19パンデミックのような世界の健康課題や社会的圧力は、不安関連障害の急増に寄与しており、治療を必要とする人々のプールをさらに拡大しています。デジタルヘルスと遠隔精神医学へのシフトは、セラピストが農村部や十分なサービスを受けていない人々に手を差し伸べることを可能にし、アクセスのギャップを埋め、早期介入を促しています。学校、職場、コミュニティセンターでは、早期発見と治療への偏見をなくすためのスクリーニングや教育プログラムを提供するところが増えています。文化的障壁がなくなり続け、多くの国で心理的疾患に対する保険適用が改善されるにつれて、恐怖症治療の患者層は広がり続けています。このように、恐怖症が正当な病状であると認識されつつあることと、治療へのアクセスが向上していることが、治療ソリューションの世界市場の拡大を大きく後押ししています。

治療と技術の革新は恐怖症治療にどのような革命をもたらしているか？

技術の進歩と治療法の革新は、恐怖症の診断、管理、治療方法を大きく変えつつあります。伝統的な認知行動療法（CBT）は、ほとんどの恐怖症治療のゴールドスタンダードであり続けているが、最新の改良により、これらのアプローチはより個別化され、効果的なものとなっています。バーチャルリアリティ暴露療法（VRET）は、特に飛行機恐怖症、高所恐怖症、人前で話すことへの恐怖症など、特定の恐怖症の治療に大きな支持を得ています。管理された環境をシミュレートすることで、VRETは患者が安全で構造化された環境で恐怖と向き合い、感覚を麻痺させることを可能にします。さらに、AIを搭載したメンタルヘルス・プラットフォームは現在、アルゴリズムを使用して不安レベルを評価し、治療計画を提案し、さらにはガイド付き治療セッションを提供しています。曝露訓練、気分の追跡、バーチャルコーチングを組み込んだモバイルアプリは、患者が専門家によるセッションの合間に自己主導的な治療に取り組む力を与えています。薬理学的な進歩も治療に貢献しており、選択的セロトニン再取り込み阻害薬（SSRI）、β遮断薬、抗不安薬が、急性症状を軽減し治療成果をサポートするために選択的に使用されています。機能的MRIやニューロフィードバック技術は、臨床医が恐怖症の背後にある神経学的メカニズムをより深く理解するのに役立っており、より的を絞った介入への扉を開く可能性があります。集団療法やマインドフルネスに基づく認知療法も、特に仲間との交流や感情的な確認から恩恵を受ける患者の間で人気を集めています。神経科学、デジタル治療学、心理学研究の融合は、臨床・非臨床を問わず多様な患者のニーズに対応する、より強固で応答性の高いエコシステムを恐怖症治療にもたらしつつあります。

恐怖症治療のアクセシビリティと普及を形作る社会的要因とヘルスケア要因とは？

恐怖症治療のアクセシビリティと普及は、社会的態度、ヘルスケアインフラ、教育普及活動の組み合わせに大きく影響されます。多くの低・中所得国では、メンタルヘルスケアはまだ資金不足であり、公衆衛生システムへの統合も不十分であるため、資格を持ったセラピストや精神科医が限られています。この不足は、精神疾患をめぐる文化的タブーや誤解によって悪化することが多く、個人が自分の恐れを認めたり、助けを求めたりすることを妨げています。対照的に、メンタルヘルス・プログラムが充実し、訓練を受けた専門家がいて、保険が適用されている高所得国では、治療率が著しく高く、長期的な転帰も良好です。恐怖症に対する社会の認識を変え、早期診断を促す上で、政府組織と非政府組織の両方が支援する啓発キャンペーンが極めて重要な役割を果たしています。学校や大学では、カウンセリング・サービスを利用できるようになってきており、これは、社会的恐怖症やパフォーマンスに関連した恐怖症に陥りやすい若年層へのアプローチに不可欠です。雇用主もまた、未治療の不安障害が生産性や欠勤に与える影響を認識しており、多くの企業がヘルスケアパッケージにメンタルヘルス給付や従業員支援プログラムを組み込んでいます。しかし、農村部と都市部とのアクセス、言葉の壁、医療費の負担などの点で格差があり、メンタルヘルスケアの公平性が喫緊の課題となっています。こうした格差をなくすためには、遠隔治療のインフラ、地域に根ざした介入、メンタルヘルス教育への継続的な投資が不可欠です。ヘルスケアシステムがより総合的なアプローチへと進化する中、日常的な医療サービスに心理ケアを統合することは、世界的に恐怖症治療の範囲と影響を拡大する上で不可欠です。

恐怖症治療ソリューションの世界的拡大と革新の原動力は？

恐怖症治療市場の成長は、科学の進歩、患者の行動、世界の医療政策に関連するいくつかの要因によってもたらされます。主な要因のひとつは、不安障害の有病率の増加であり、その中でも恐怖症は大きな割合を占めています。診断ツールやスクリーニングの方法がより正確で広く行われるようになるにつれて、より多くの症例が特定され、適切な治療経路に導かれるようになっています。遠隔医療サービスやメンタルヘルス・アプリの拡大は、セラピーをより身近で目立たないものにし、技術に精通した若い世代や遠隔地の人々を含む幅広い層にアピールしています。臨床面では、曝露療法、バーチャルリアリティ環境、神経刺激療法などの革新が、より没入感のある個別化された治療体験を生み出しています。医薬品の開発も一役買っており、抗不安薬の忍容性と有効性が改善されたことで、患者のコンプライアンスと治療成績が向上しています。メンタルヘルスが公衆衛生の優先課題であるという開発政府の認識により、資金が増加し、普遍的ヘルスケアモデルにメンタルヘルスサービスが組み込まれ、恐怖症や不安管理のための対象プログラムが開発されました。職場の健康増進への取り組みやメンタルヘルスサービスに対する保険適用の増加は、利用しやすく費用対効果の高い治療への需要をさらに刺激しています。これと並行して、消費者の嗜好は非侵襲的、治療ベース、統合的な治療オプションへとシフトしており、マインドフルネス、ホリスティックカウンセリング、デジタルCBTプラットフォームの成長をもたらしています。こうした動向が交錯することで、ダイナミックでイノベーション主導の環境が醸成され、世界の恐怖症治療市場は加速度的に前進しています。

セグメント

恐怖症タイプ（動物恐怖症、先端恐怖症、広場恐怖症、閉所恐怖症、社会恐怖症、その他の恐怖症タイプ）;治療法（セラピー、薬物療法）;エンドユーザー（病院エンドユーザー、精神科クリニックエンドユーザー、恐怖症治療センターエンドユーザー、その他のエンドユーザー）

調査対象企業の例

• AbleTo
• Ada Health
• Alkermes
• AMW GmbH
• AppliedVR
• Atai Life Sciences
• Big Health
• Braingaze
• Cerebral
• Compass Pathways
• Headspace Health
• Limbix
• Lyra Health
• MindMaze
• Mindstrong
• Modern Health
• Novartis
• Talkspace
• Teladoc Health
• Woebot Health

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Phobia Treatment Market to Reach US$2.4 Billion by 2030

The global market for Phobia Treatment estimated at US$1.9 Billion in the year 2024, is expected to reach US$2.4 Billion by 2030, growing at a CAGR of 4.0% over the analysis period 2024-2030. Zoophobia, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$771.5 Million by the end of the analysis period. Growth in the Acrophobia segment is estimated at 2.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$527.0 Million While China is Forecast to Grow at 7.5% CAGR

The Phobia Treatment market in the U.S. is estimated at US$527.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$502.4 Million by the year 2030 trailing a CAGR of 7.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.5% and 3.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.3% CAGR.

Global Phobia Treatment Market - Key Trends & Drivers Summarized

Why Is the Demand for Phobia Treatment Rising Across Demographics and Regions?

Phobias, categorized as intense and irrational fears of specific objects, situations, or activities, are increasingly being recognized as serious mental health conditions requiring professional intervention. With growing awareness around mental health, both in developed and developing regions, more individuals are seeking treatment for various types of phobias, including social phobia, agoraphobia, specific phobias like fear of heights, spiders, flying, or enclosed spaces. The stigma that once surrounded psychological conditions is gradually decreasing, which has encouraged more people to pursue diagnosis and therapy. In parallel, healthcare systems and governments are integrating mental health services into primary care, making phobia treatment more accessible. Furthermore, global health challenges and social pressures, such as the COVID-19 pandemic, have contributed to a spike in anxiety-related disorders, further expanding the pool of individuals requiring treatment. The shift toward digital health and telepsychiatry has also allowed therapists to reach rural and underserved populations, bridging access gaps and encouraging early intervention. Schools, workplaces, and community centers are increasingly offering screenings and educational programs that promote early identification and destigmatize treatment. As cultural barriers continue to erode and insurance coverage for psychological conditions improves in many countries, the patient base for phobia treatment continues to widen. This growing recognition of phobias as legitimate medical conditions, combined with enhanced access to care, is significantly driving the expansion of the global market for treatment solutions.

How Are Innovations in Therapy and Technology Revolutionizing Phobia Treatment?

Technological advancements and therapeutic innovations are profoundly transforming how phobias are diagnosed, managed, and treated. Traditional cognitive-behavioral therapy (CBT) remains the gold standard for most phobia treatments, but modern enhancements are making these approaches more personalized and effective. Virtual reality exposure therapy (VRET) is gaining significant traction, especially for treating specific phobias like fear of flying, heights, or public speaking. By simulating controlled environments, VRET allows patients to confront and desensitize their fears in a safe, structured setting. Additionally, AI-powered mental health platforms are now using algorithms to assess anxiety levels, suggest treatment plans, and even provide guided therapy sessions. Mobile apps with built-in exposure exercises, mood tracking, and virtual coaching have empowered patients to engage in self-directed therapy between professional sessions. Pharmacological advancements are also contributing to treatment, with selective serotonin reuptake inhibitors (SSRIs), beta blockers, and anxiolytics being used selectively to reduce acute symptoms and support therapy outcomes. Functional MRI and neurofeedback technologies are helping clinicians gain deeper insights into the neurological mechanisms behind phobias, potentially opening doors to even more targeted interventions. Group therapy and mindfulness-based cognitive therapy are also gaining popularity, particularly among patients who benefit from peer interaction and emotional validation. The convergence of neuroscience, digital therapeutics, and psychological research is creating a more robust and responsive ecosystem for phobia treatment that caters to diverse patient needs across clinical and non-clinical settings.

What Societal and Healthcare Factors Shape the Accessibility and Uptake of Phobia Treatment?

The accessibility and adoption of phobia treatment are heavily influenced by a combination of societal attitudes, healthcare infrastructure, and educational outreach. In many low- and middle-income countries, mental health care is still underfunded and poorly integrated into public health systems, resulting in limited availability of qualified therapists and psychiatrists. This shortage is often exacerbated by cultural taboos and misconceptions surrounding mental illness, which discourage individuals from acknowledging their fears or seeking help. In contrast, high-income countries with robust mental health programs, trained professionals, and insurance coverage have significantly higher treatment rates and better long-term outcomes. Public awareness campaigns, supported by both governmental and non-governmental organizations, have played a pivotal role in reshaping societal perceptions about phobias and encouraging early diagnosis. Schools and universities are increasingly providing access to counseling services, which is essential in reaching younger populations who are vulnerable to social and performance-related phobias. Employers are also recognizing the impact of untreated anxiety disorders on productivity and absenteeism, leading many to include mental health benefits and employee assistance programs in their healthcare packages. However, disparities persist in terms of rural versus urban access, language barriers, and affordability, making equity in mental health care a pressing issue. Continued investments in teletherapy infrastructure, community-based interventions, and mental health education are crucial to closing these gaps. As healthcare systems evolve toward a more holistic approach, the integration of psychological care into routine health services will be vital in expanding the reach and impact of phobia treatment worldwide.

What Drives the Global Expansion and Innovation in Phobia Treatment Solutions?

The growth in the phobia treatment market is driven by several factors related to scientific progress, patient behavior, and the global health policy landscape. One of the primary drivers is the increasing prevalence of anxiety disorders, with phobias comprising a substantial share of these conditions. As diagnostic tools and screening practices become more precise and widespread, more cases are being identified and funneled into appropriate treatment pathways. The expansion of telehealth services and mental health apps has made therapy more accessible and discreet, appealing to a broader demographic that includes tech-savvy younger generations and individuals in remote regions. On the clinical side, innovations in exposure-based therapy, virtual reality environments, and neurostimulation are creating more immersive and individualized treatment experiences. Pharmaceutical developments are also playing a role, with improved tolerability and efficacy of anti-anxiety medications enhancing patient compliance and outcomes. Governmental recognition of mental health as a public health priority has led to increased funding, inclusion of mental health services in universal healthcare models, and the development of targeted programs for phobia and anxiety management. The rise of workplace wellness initiatives and insurance coverage for mental health services further stimulates demand for accessible and cost-effective treatments. In parallel, consumer preferences are shifting toward non-invasive, therapy-based, and integrative treatment options, leading to the growth of mindfulness, holistic counseling, and digital CBT platforms. These intersecting trends are fostering a dynamic, innovation-driven environment that is propelling the global phobia treatment market forward at an accelerating pace.

SCOPE OF STUDY:

The report analyzes the Phobia Treatment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Phobia Type (Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia, Other Phobia Types); Treatment (Therapy , Medication); End-Use (Hospitals End-Use, Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

• AbleTo
• Ada Health
• Alkermes
• AMW GmbH
• AppliedVR
• Atai Life Sciences
• Big Health
• Braingaze
• Cerebral
• Compass Pathways
• Headspace Health
• Limbix
• Lyra Health
• MindMaze
• Mindstrong
• Modern Health
• Novartis
• Talkspace
• Teladoc Health
• Woebot Health

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Phobia Treatment - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Global Awareness of Mental Health Issues Propels Demand for Effective Phobia Treatment Options
  • Increased Willingness to Seek Help Expands the Addressable Market for Evidence-Based Therapies
  • Advancements in Cognitive Behavioral Therapy (CBT) Strengthen the Business Case for Structured Phobia Treatment
  • Growth in Digital Therapeutics and App-Based CBT Solutions Drives Adoption in Younger Populations
  • Virtual Reality (VR) Exposure Therapy Throws the Spotlight on Immersive, Technology-Driven Treatment Models
  • Telepsychiatry and Remote Counseling Services Accelerate Access to Specialized Phobia Treatment Providers
  • Integration of AI and Personalized Therapy Tools Enhances Engagement and Clinical Outcomes
  • Rising Demand for Non-Pharmacological Interventions Spurs Development of Mindfulness and Relaxation-Based Therapies
  • Increased Use of SSRIs and Beta Blockers in Severe Cases Sustains Pharmacological Treatment Demand
  • Stigma Reduction Campaigns and Mental Health Advocacy Strengthen Public Receptiveness to Treatment
  • Growth of Private Mental Health Clinics and Wellness Platforms Fuels Availability of Specialized Phobia Care
  • Clinical Research in Neuroplasticity and Fear Extinction Drives Innovation in Next-Generation Therapies
  • Global Digital Health Investments Create Momentum for Scalable, Low-Cost Treatment Delivery Platforms
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Phobia Treatment Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Phobia Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Phobia Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Phobia Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Zoophobia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Zoophobia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Zoophobia by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Acrophobia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Acrophobia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Acrophobia by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Agoraphobia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Agoraphobia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Agoraphobia by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Claustrophobia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Claustrophobia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Claustrophobia by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Social Phobia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Social Phobia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Social Phobia by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Other Phobia Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Other Phobia Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Other Phobia Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Psychiatry Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Psychiatry Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Psychiatry Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Phobia Treatment Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Phobia Treatment Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Phobia Treatment Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 31: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 34: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 37: World 16-Year Perspective for Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Medication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Medication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 40: World 16-Year Perspective for Medication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Phobia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 41: USA Recent Past, Current & Future Analysis for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 43: USA 16-Year Perspective for Phobia Treatment by Phobia Type - Percentage Breakdown of Value Sales for Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types for the Years 2014, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 46: USA 16-Year Perspective for Phobia Treatment by End-Use - Percentage Breakdown of Value Sales for Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2014, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Phobia Treatment by Treatment - Therapy and Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Phobia Treatment by Treatment - Therapy and Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 49: USA 16-Year Perspective for Phobia Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Medication for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 52: Canada 16-Year Perspective for Phobia Treatment by Phobia Type - Percentage Breakdown of Value Sales for Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types for the Years 2014, 2025 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 55: Canada 16-Year Perspective for Phobia Treatment by End-Use - Percentage Breakdown of Value Sales for Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2014, 2025 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Phobia Treatment by Treatment - Therapy and Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Phobia Treatment by Treatment - Therapy and Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 58: Canada 16-Year Perspective for Phobia Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Medication for the Years 2014, 2025 & 2030
• JAPAN
  • Phobia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 61: Japan 16-Year Perspective for Phobia Treatment by Phobia Type - Percentage Breakdown of Value Sales for Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types for the Years 2014, 2025 & 2030
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 64: Japan 16-Year Perspective for Phobia Treatment by End-Use - Percentage Breakdown of Value Sales for Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2014, 2025 & 2030
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Phobia Treatment by Treatment - Therapy and Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Phobia Treatment by Treatment - Therapy and Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 67: Japan 16-Year Perspective for Phobia Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Medication for the Years 2014, 2025 & 2030
• CHINA
  • Phobia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 68: China Recent Past, Current & Future Analysis for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 70: China 16-Year Perspective for Phobia Treatment by Phobia Type - Percentage Breakdown of Value Sales for Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types for the Years 2014, 2025 & 2030
  • TABLE 71: China Recent Past, Current & Future Analysis for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 73: China 16-Year Perspective for Phobia Treatment by End-Use - Percentage Breakdown of Value Sales for Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2014, 2025 & 2030
  • TABLE 74: China Recent Past, Current & Future Analysis for Phobia Treatment by Treatment - Therapy and Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Phobia Treatment by Treatment - Therapy and Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 76: China 16-Year Perspective for Phobia Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Medication for the Years 2014, 2025 & 2030
• EUROPE
  • Phobia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Phobia Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Phobia Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 79: Europe 16-Year Perspective for Phobia Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 82: Europe 16-Year Perspective for Phobia Treatment by Phobia Type - Percentage Breakdown of Value Sales for Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types for the Years 2014, 2025 & 2030
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 85: Europe 16-Year Perspective for Phobia Treatment by End-Use - Percentage Breakdown of Value Sales for Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2014, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Phobia Treatment by Treatment - Therapy and Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Phobia Treatment by Treatment - Therapy and Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 88: Europe 16-Year Perspective for Phobia Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Medication for the Years 2014, 2025 & 2030
• FRANCE
  • Phobia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 89: France Recent Past, Current & Future Analysis for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 91: France 16-Year Perspective for Phobia Treatment by Phobia Type - Percentage Breakdown of Value Sales for Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types for the Years 2014, 2025 & 2030
  • TABLE 92: France Recent Past, Current & Future Analysis for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: France Historic Review for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 94: France 16-Year Perspective for Phobia Treatment by End-Use - Percentage Breakdown of Value Sales for Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2014, 2025 & 2030
  • TABLE 95: France Recent Past, Current & Future Analysis for Phobia Treatment by Treatment - Therapy and Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: France Historic Review for Phobia Treatment by Treatment - Therapy and Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 97: France 16-Year Perspective for Phobia Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Medication for the Years 2014, 2025 & 2030
• GERMANY
  • Phobia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 98: Germany Recent Past, Current & Future Analysis for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 100: Germany 16-Year Perspective for Phobia Treatment by Phobia Type - Percentage Breakdown of Value Sales for Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types for the Years 2014, 2025 & 2030
  • TABLE 101: Germany Recent Past, Current & Future Analysis for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Germany Historic Review for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 103: Germany 16-Year Perspective for Phobia Treatment by End-Use - Percentage Breakdown of Value Sales for Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2014, 2025 & 2030
  • TABLE 104: Germany Recent Past, Current & Future Analysis for Phobia Treatment by Treatment - Therapy and Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Germany Historic Review for Phobia Treatment by Treatment - Therapy and Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 106: Germany 16-Year Perspective for Phobia Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Medication for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 107: Italy Recent Past, Current & Future Analysis for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 109: Italy 16-Year Perspective for Phobia Treatment by Phobia Type - Percentage Breakdown of Value Sales for Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types for the Years 2014, 2025 & 2030
  • TABLE 110: Italy Recent Past, Current & Future Analysis for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Italy Historic Review for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 112: Italy 16-Year Perspective for Phobia Treatment by End-Use - Percentage Breakdown of Value Sales for Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2014, 2025 & 2030
  • TABLE 113: Italy Recent Past, Current & Future Analysis for Phobia Treatment by Treatment - Therapy and Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Italy Historic Review for Phobia Treatment by Treatment - Therapy and Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 115: Italy 16-Year Perspective for Phobia Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Medication for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Phobia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 116: UK Recent Past, Current & Future Analysis for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 118: UK 16-Year Perspective for Phobia Treatment by Phobia Type - Percentage Breakdown of Value Sales for Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types for the Years 2014, 2025 & 2030
  • TABLE 119: UK Recent Past, Current & Future Analysis for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: UK Historic Review for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 121: UK 16-Year Perspective for Phobia Treatment by End-Use - Percentage Breakdown of Value Sales for Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2014, 2025 & 2030
  • TABLE 122: UK Recent Past, Current & Future Analysis for Phobia Treatment by Treatment - Therapy and Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: UK Historic Review for Phobia Treatment by Treatment - Therapy and Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 124: UK 16-Year Perspective for Phobia Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Medication for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 125: Spain Recent Past, Current & Future Analysis for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 127: Spain 16-Year Perspective for Phobia Treatment by Phobia Type - Percentage Breakdown of Value Sales for Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types for the Years 2014, 2025 & 2030
  • TABLE 128: Spain Recent Past, Current & Future Analysis for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Spain Historic Review for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 130: Spain 16-Year Perspective for Phobia Treatment by End-Use - Percentage Breakdown of Value Sales for Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2014, 2025 & 2030
  • TABLE 131: Spain Recent Past, Current & Future Analysis for Phobia Treatment by Treatment - Therapy and Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Spain Historic Review for Phobia Treatment by Treatment - Therapy and Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 133: Spain 16-Year Perspective for Phobia Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Medication for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 134: Russia Recent Past, Current & Future Analysis for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 136: Russia 16-Year Perspective for Phobia Treatment by Phobia Type - Percentage Breakdown of Value Sales for Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types for the Years 2014, 2025 & 2030
  • TABLE 137: Russia Recent Past, Current & Future Analysis for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Russia Historic Review for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 139: Russia 16-Year Perspective for Phobia Treatment by End-Use - Percentage Breakdown of Value Sales for Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2014, 2025 & 2030
  • TABLE 140: Russia Recent Past, Current & Future Analysis for Phobia Treatment by Treatment - Therapy and Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Russia Historic Review for Phobia Treatment by Treatment - Therapy and Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 142: Russia 16-Year Perspective for Phobia Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Medication for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 16-Year Perspective for Phobia Treatment by Phobia Type - Percentage Breakdown of Value Sales for Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types for the Years 2014, 2025 & 2030
  • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Europe Historic Review for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 148: Rest of Europe 16-Year Perspective for Phobia Treatment by End-Use - Percentage Breakdown of Value Sales for Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2014, 2025 & 2030
  • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Phobia Treatment by Treatment - Therapy and Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Rest of Europe Historic Review for Phobia Treatment by Treatment - Therapy and Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 151: Rest of Europe 16-Year Perspective for Phobia Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Medication for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Phobia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Phobia Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Phobia Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 16-Year Perspective for Phobia Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 16-Year Perspective for Phobia Treatment by Phobia Type - Percentage Breakdown of Value Sales for Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types for the Years 2014, 2025 & 2030
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 16-Year Perspective for Phobia Treatment by End-Use - Percentage Breakdown of Value Sales for Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2014, 2025 & 2030
  • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Phobia Treatment by Treatment - Therapy and Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Asia-Pacific Historic Review for Phobia Treatment by Treatment - Therapy and Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 163: Asia-Pacific 16-Year Perspective for Phobia Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Medication for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Phobia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 164: Australia Recent Past, Current & Future Analysis for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 166: Australia 16-Year Perspective for Phobia Treatment by Phobia Type - Percentage Breakdown of Value Sales for Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types for the Years 2014, 2025 & 2030
  • TABLE 167: Australia Recent Past, Current & Future Analysis for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Australia Historic Review for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 169: Australia 16-Year Perspective for Phobia Treatment by End-Use - Percentage Breakdown of Value Sales for Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2014, 2025 & 2030
  • TABLE 170: Australia Recent Past, Current & Future Analysis for Phobia Treatment by Treatment - Therapy and Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Australia Historic Review for Phobia Treatment by Treatment - Therapy and Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 172: Australia 16-Year Perspective for Phobia Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Medication for the Years 2014, 2025 & 2030
• INDIA
  • Phobia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 173: India Recent Past, Current & Future Analysis for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 175: India 16-Year Perspective for Phobia Treatment by Phobia Type - Percentage Breakdown of Value Sales for Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types for the Years 2014, 2025 & 2030
  • TABLE 176: India Recent Past, Current & Future Analysis for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: India Historic Review for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 178: India 16-Year Perspective for Phobia Treatment by End-Use - Percentage Breakdown of Value Sales for Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2014, 2025 & 2030
  • TABLE 179: India Recent Past, Current & Future Analysis for Phobia Treatment by Treatment - Therapy and Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: India Historic Review for Phobia Treatment by Treatment - Therapy and Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 181: India 16-Year Perspective for Phobia Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Medication for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 184: South Korea 16-Year Perspective for Phobia Treatment by Phobia Type - Percentage Breakdown of Value Sales for Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types for the Years 2014, 2025 & 2030
  • TABLE 185: South Korea Recent Past, Current & Future Analysis for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: South Korea Historic Review for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 187: South Korea 16-Year Perspective for Phobia Treatment by End-Use - Percentage Breakdown of Value Sales for Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2014, 2025 & 2030
  • TABLE 188: South Korea Recent Past, Current & Future Analysis for Phobia Treatment by Treatment - Therapy and Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 189: South Korea Historic Review for Phobia Treatment by Treatment - Therapy and Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 190: South Korea 16-Year Perspective for Phobia Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Medication for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 16-Year Perspective for Phobia Treatment by Phobia Type - Percentage Breakdown of Value Sales for Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types for the Years 2014, 2025 & 2030
  • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Asia-Pacific Historic Review for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 196: Rest of Asia-Pacific 16-Year Perspective for Phobia Treatment by End-Use - Percentage Breakdown of Value Sales for Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2014, 2025 & 2030
  • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Phobia Treatment by Treatment - Therapy and Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Asia-Pacific Historic Review for Phobia Treatment by Treatment - Therapy and Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 199: Rest of Asia-Pacific 16-Year Perspective for Phobia Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Medication for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Phobia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Phobia Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Phobia Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 202: Latin America 16-Year Perspective for Phobia Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 205: Latin America 16-Year Perspective for Phobia Treatment by Phobia Type - Percentage Breakdown of Value Sales for Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types for the Years 2014, 2025 & 2030
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 208: Latin America 16-Year Perspective for Phobia Treatment by End-Use - Percentage Breakdown of Value Sales for Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2014, 2025 & 2030
  • TABLE 209: Latin America Recent Past, Current & Future Analysis for Phobia Treatment by Treatment - Therapy and Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Latin America Historic Review for Phobia Treatment by Treatment - Therapy and Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 211: Latin America 16-Year Perspective for Phobia Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Medication for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 214: Argentina 16-Year Perspective for Phobia Treatment by Phobia Type - Percentage Breakdown of Value Sales for Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types for the Years 2014, 2025 & 2030
  • TABLE 215: Argentina Recent Past, Current & Future Analysis for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Argentina Historic Review for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 217: Argentina 16-Year Perspective for Phobia Treatment by End-Use - Percentage Breakdown of Value Sales for Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2014, 2025 & 2030
  • TABLE 218: Argentina Recent Past, Current & Future Analysis for Phobia Treatment by Treatment - Therapy and Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Argentina Historic Review for Phobia Treatment by Treatment - Therapy and Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 220: Argentina 16-Year Perspective for Phobia Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Medication for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 223: Brazil 16-Year Perspective for Phobia Treatment by Phobia Type - Percentage Breakdown of Value Sales for Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types for the Years 2014, 2025 & 2030
  • TABLE 224: Brazil Recent Past, Current & Future Analysis for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Brazil Historic Review for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 226: Brazil 16-Year Perspective for Phobia Treatment by End-Use - Percentage Breakdown of Value Sales for Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2014, 2025 & 2030
  • TABLE 227: Brazil Recent Past, Current & Future Analysis for Phobia Treatment by Treatment - Therapy and Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Brazil Historic Review for Phobia Treatment by Treatment - Therapy and Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 229: Brazil 16-Year Perspective for Phobia Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Medication for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 232: Mexico 16-Year Perspective for Phobia Treatment by Phobia Type - Percentage Breakdown of Value Sales for Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types for the Years 2014, 2025 & 2030
  • TABLE 233: Mexico Recent Past, Current & Future Analysis for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Mexico Historic Review for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 235: Mexico 16-Year Perspective for Phobia Treatment by End-Use - Percentage Breakdown of Value Sales for Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2014, 2025 & 2030
  • TABLE 236: Mexico Recent Past, Current & Future Analysis for Phobia Treatment by Treatment - Therapy and Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Mexico Historic Review for Phobia Treatment by Treatment - Therapy and Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 238: Mexico 16-Year Perspective for Phobia Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Medication for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 16-Year Perspective for Phobia Treatment by Phobia Type - Percentage Breakdown of Value Sales for Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types for the Years 2014, 2025 & 2030
  • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Latin America Historic Review for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 244: Rest of Latin America 16-Year Perspective for Phobia Treatment by End-Use - Percentage Breakdown of Value Sales for Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2014, 2025 & 2030
  • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Phobia Treatment by Treatment - Therapy and Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Latin America Historic Review for Phobia Treatment by Treatment - Therapy and Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 247: Rest of Latin America 16-Year Perspective for Phobia Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Medication for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Phobia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Phobia Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Phobia Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 250: Middle East 16-Year Perspective for Phobia Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 253: Middle East 16-Year Perspective for Phobia Treatment by Phobia Type - Percentage Breakdown of Value Sales for Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types for the Years 2014, 2025 & 2030
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 256: Middle East 16-Year Perspective for Phobia Treatment by End-Use - Percentage Breakdown of Value Sales for Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2014, 2025 & 2030
  • TABLE 257: Middle East Recent Past, Current & Future Analysis for Phobia Treatment by Treatment - Therapy and Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Middle East Historic Review for Phobia Treatment by Treatment - Therapy and Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 259: Middle East 16-Year Perspective for Phobia Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Medication for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 260: Iran Recent Past, Current & Future Analysis for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 262: Iran 16-Year Perspective for Phobia Treatment by Phobia Type - Percentage Breakdown of Value Sales for Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types for the Years 2014, 2025 & 2030
  • TABLE 263: Iran Recent Past, Current & Future Analysis for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Iran Historic Review for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 265: Iran 16-Year Perspective for Phobia Treatment by End-Use - Percentage Breakdown of Value Sales for Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2014, 2025 & 2030
  • TABLE 266: Iran Recent Past, Current & Future Analysis for Phobia Treatment by Treatment - Therapy and Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Iran Historic Review for Phobia Treatment by Treatment - Therapy and Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 268: Iran 16-Year Perspective for Phobia Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Medication for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 269: Israel Recent Past, Current & Future Analysis for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 271: Israel 16-Year Perspective for Phobia Treatment by Phobia Type - Percentage Breakdown of Value Sales for Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types for the Years 2014, 2025 & 2030
  • TABLE 272: Israel Recent Past, Current & Future Analysis for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Israel Historic Review for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 274: Israel 16-Year Perspective for Phobia Treatment by End-Use - Percentage Breakdown of Value Sales for Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2014, 2025 & 2030
  • TABLE 275: Israel Recent Past, Current & Future Analysis for Phobia Treatment by Treatment - Therapy and Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Israel Historic Review for Phobia Treatment by Treatment - Therapy and Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 277: Israel 16-Year Perspective for Phobia Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Medication for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 16-Year Perspective for Phobia Treatment by Phobia Type - Percentage Breakdown of Value Sales for Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types for the Years 2014, 2025 & 2030
  • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Saudi Arabia Historic Review for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 283: Saudi Arabia 16-Year Perspective for Phobia Treatment by End-Use - Percentage Breakdown of Value Sales for Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2014, 2025 & 2030
  • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Phobia Treatment by Treatment - Therapy and Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Saudi Arabia Historic Review for Phobia Treatment by Treatment - Therapy and Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 286: Saudi Arabia 16-Year Perspective for Phobia Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Medication for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 287: UAE Recent Past, Current & Future Analysis for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 289: UAE 16-Year Perspective for Phobia Treatment by Phobia Type - Percentage Breakdown of Value Sales for Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types for the Years 2014, 2025 & 2030
  • TABLE 290: UAE Recent Past, Current & Future Analysis for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: UAE Historic Review for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 292: UAE 16-Year Perspective for Phobia Treatment by End-Use - Percentage Breakdown of Value Sales for Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2014, 2025 & 2030
  • TABLE 293: UAE Recent Past, Current & Future Analysis for Phobia Treatment by Treatment - Therapy and Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: UAE Historic Review for Phobia Treatment by Treatment - Therapy and Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 295: UAE 16-Year Perspective for Phobia Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Medication for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 16-Year Perspective for Phobia Treatment by Phobia Type - Percentage Breakdown of Value Sales for Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types for the Years 2014, 2025 & 2030
  • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Middle East Historic Review for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 301: Rest of Middle East 16-Year Perspective for Phobia Treatment by End-Use - Percentage Breakdown of Value Sales for Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2014, 2025 & 2030
  • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Phobia Treatment by Treatment - Therapy and Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Middle East Historic Review for Phobia Treatment by Treatment - Therapy and Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 304: Rest of Middle East 16-Year Perspective for Phobia Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Medication for the Years 2014, 2025 & 2030
• AFRICA
  • Phobia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 305: Africa Recent Past, Current & Future Analysis for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for Phobia Treatment by Phobia Type - Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 307: Africa 16-Year Perspective for Phobia Treatment by Phobia Type - Percentage Breakdown of Value Sales for Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia and Other Phobia Types for the Years 2014, 2025 & 2030
  • TABLE 308: Africa Recent Past, Current & Future Analysis for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Africa Historic Review for Phobia Treatment by End-Use - Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 310: Africa 16-Year Perspective for Phobia Treatment by End-Use - Percentage Breakdown of Value Sales for Psychiatry Clinics End-Use, Phobia Treatment Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2014, 2025 & 2030
  • TABLE 311: Africa Recent Past, Current & Future Analysis for Phobia Treatment by Treatment - Therapy and Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Africa Historic Review for Phobia Treatment by Treatment - Therapy and Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 313: Africa 16-Year Perspective for Phobia Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Medication for the Years 2014, 2025 & 2030

IV. COMPETITION